+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prediction of post-treatment hypothyroidism using changes in thyroid volume after radioactive iodine therapy in adolescent patients with Graves' disease

Prediction of post-treatment hypothyroidism using changes in thyroid volume after radioactive iodine therapy in adolescent patients with Graves' disease

International Journal of Pediatric Endocrinology 2011: 14

The goal of iodine-131 therapy for pediatric Graves' disease is to induce hypothyroidism. However, changes in post-treatment thyroid volume have not been investigated in pediatric and/or adolescent patients. The aim of this retrospective study was to examine whether changes in thyroid volume predict post-treatment hypothyroidism in adolescent Graves' disease patients. We used ultrasonography to examine changes in thyroid volume, and also assessed thyroid functions, at 0, 1, 3, 5, 8 and 12 months after iodine-131 treatment in 49 adolescents ranging in age from 12 to 19 years retrospectively. Based on thyroid function outcome at 12 months, patients were divided into two groups: 29 patients with overt hypothyroidism requiring levothyroxine replacement and 20 without overt hypothyroidism. We compared changes in post-radioiodine thyroid volume between the two groups. About 90% of patients whose thyroid volume at 3 months after iodine-131 administration was less than 50% of the original volume were hypothyroid by one year after treatment (positive predictive value 88%, sensitivity 75.9%, specificity 85.0%). We believe ultrasonographic measurement of thyroid volume at 3 months after iodine-131 to be clinically useful for predicting post-treatment hypothyroidism in adolescent Graves' disease patients.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 055104991

Download citation: RISBibTeXText

PMID: 22060749

DOI: 10.1186/1687-9856-2011-14

Related references

Thyroid Isthmus Length and Iodine Turnover as Predictors of Successful Radioactive Iodine Therapy in Patients with Graves' Disease. International Journal of Endocrinology 2017: 7354673, 2018

Radioactive iodine in the study of thyroid physiology; the use of radioactive iodine therapy in Graves' disease. Western Journal of Surgery, Obstetrics, and Gynecology 54(12): 474-486, 2011

No impact of dietary iodine restriction in short term development of hypothyroidism following fixed dose radioactive iodine therapy for Graves' disease. Indian Journal of Endocrinology and Metabolism 19(1): 60-65, 2015

Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease. American Journal of Medicine 99(2): 173-179, 1995

Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease. Thyroid 5(4): 243-247, 1995

Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome. Journal of Clinical Endocrinology and Metabolism 81(9): 3257-3260, 1996

Acute psychosis caused by hypothyroidism following radioactive iodine treatment of Graves' disease. Jrsm Short Reports 4(4): 26, 2013

Thyroid carcinoma after radioactive iodine therapy for Graves' disease. World Journal of Surgery 18(4): 518-521, 1994

The Incidence of Hypothyroidism Following the Radioactive Iodine Treatment of Graves' Disease and the Predictive Factors Influencing its Development. World Journal of Nuclear Medicine 15(1): 30-37, 2016

Hypothyroidism and hyponatremia: data from a series of patients with iatrogenic acute hypothyroidism undergoing radioactive iodine therapy after total thyroidectomy for thyroid cancer. Journal of Endocrinological Investigation 40(1): 49-54, 2016

Thyroid storm following radioactive iodine (RAI) therapy for pediatric graves disease. American Journal of Case Reports 15: 212-215, 2014

Anaplastic thyroid carcinoma following radioactive iodine therapy for graves' disease. Endocrinology and Metabolism 28(1): 61-64, 2014

Radioactive Iodine As An Indicator In Thyroid Physiology. V. The Use Of Radioactive Iodine In The Differential Diagnosis Of Two Types Of Graves' Disease. Journal of Clinical Investigation 21(1): 31-32, 1942

Clinical experience with radioactive iodine in the treatment of childhood and adolescent Graves' disease. Endocrine Connections 2(1): 32-37, 2013

Follicular carcinoma of the thyroid following radioactive iodine treatment for Graves' disease. Postgraduate Medical Journal 64(757): 878-880, 1988